Medindia

X

Gardasil Appears More Cost-Effective Than Cervarix

by Kathy Jones on  September 30, 2011 at 10:58 PM Cancer News   - G J E 4
A new study published in the British Medical Journal suggests that Merck's cervical cancer vaccine, Gardasil, was more cost effective than the popularly used Cervarix manufactured by GlaxoSmithKline's (GSK).
 Gardasil Appears More Cost-Effective Than Cervarix
Gardasil Appears More Cost-Effective Than Cervarix
Advertisement

The Department of Health in Britain had picked Cervarix as the cheaper option to be made available through NHS. According to the list price posted by NHS, Cervarix costs the service around £80.50 per dose compared to Gardasil's price tag of £88.50 per dose.

Advertisement
However the new study by Health Protection Agency (HPA) suggests that it is Gardasil that provides a more cost effective service compared to Cervarix.

The study said that while both the vaccines were effective against HPV types 16 and 18, Gardasil also provided protection against types 6 and 11. The researchers said that this made Gardasil a better prospect compared to Cervarix.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: